{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:24:31Z","timestamp":1782397471873,"version":"3.54.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/md.0000000000004300","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T11:39:08Z","timestamp":1475667548000},"page":"e4300","source":"Crossref","is-referenced-by-count":3,"title":["Association of \u03b2-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion"],"prefix":"10.1097","volume":"95","author":[{"given":"Jin Kyung","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hoon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-won","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Yong","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Cheol","family":"Gwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-40-20210309","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jacc.2011.12.007","article-title":"Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry","volume":"59","author":"Fefer","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R2-40-20210309","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jacc.2014.04.040","article-title":"Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database","volume":"64","author":"George","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R3-40-20210309","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ccd.25303","article-title":"Quality of life benefits of percutaneous coronary intervention for chronic occlusions","volume":"84","author":"Safley","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R4-40-20210309","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4244\/EIJV9I10A197","article-title":"Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions","volume":"9","author":"Wijeysundera","year":"2014","journal-title":"EuroIntervention"},{"key":"R5-40-20210309","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.amjcard.2014.07.034","article-title":"The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion","volume":"114","author":"Di Serafino","year":"2014","journal-title":"Am J Cardiol"},{"key":"R6-40-20210309","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"R7-40-20210309","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.160.7.947","article-title":"Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?","volume":"160","author":"Chen","year":"2000","journal-title":"Arch Intern Med"},{"key":"R8-40-20210309","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"beta-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"R9-40-20210309","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijcard.2015.06.017","article-title":"Clinical outcomes of multiple chronic total occlusions in coronary arteries according to three therapeutic strategies: bypass surgery, percutaneous intervention and medication","volume":"197","author":"Kim","year":"2015","journal-title":"Int J Cardiol"},{"key":"R10-40-20210309","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcin.2014.10.010","article-title":"Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation","volume":"8","author":"Jang","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R11-40-20210309","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ijcard.2012.12.044","article-title":"Predictors of cardiac death in patients with coronary chronic total occlusion not revascularized by PCI","volume":"168","author":"Godino","year":"2013","journal-title":"Int J Cardiol"},{"key":"R12-40-20210309","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2012.10.036","article-title":"Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion","volume":"61","author":"Valenti","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R13-40-20210309","first-page":"219","article-title":"The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"key":"R14-40-20210309","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1067\/mhj.2001.116481","article-title":"Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort","volume":"142","author":"Graham","year":"2001","journal-title":"Am Heart J"},{"key":"R15-40-20210309","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"R16-40-20210309","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2011.01.006","article-title":"Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: results from the American College of Cardiology's NCDR(\u00ae)","volume":"161","author":"Kontos","year":"2011","journal-title":"Am Heart J"},{"key":"R17-40-20210309","first-page":"57","article-title":"16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"R18-40-20210309","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"beta Blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"R19-40-20210309","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"R20-40-20210309","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"R21-40-20210309","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R22-40-20210309","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"R23-40-20210309","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCOUTCOMES.114.001073","article-title":"beta-Blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R24-40-20210309","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/heartjnl-2014-305719","article-title":"Prognostic impact of \u03b2-blocker use in patients with stable coronary artery disease","volume":"100","author":"Bauters","year":"2014","journal-title":"Heart"},{"key":"R25-40-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(95)00156-T","article-title":"Percutaneous revascularization of chronic coronary occlusions: an overview","volume":"26","author":"Puma","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R27-40-20210309","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-8703(77)80278-0","article-title":"Quantitative study on the size of coronary artery supplying areas postmortem","volume":"94","author":"Kalbfleisch","year":"1977","journal-title":"Am Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:29:25Z","timestamp":1620959365000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201607260-00040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":26,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004300","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}